Abstract
We conducted a second nationwide severe acute respiratory syndrome coronavirus 2 seroprevalence study in the Faroe Islands during November 2020. We found crude seroprevalence was 0.3% and prevalence was 0.4% after adjusting for test sensitivity and specificity. This low seroprevalence supports the prevention strategies used in the Faroe Islands.
Original language | English |
---|---|
Journal | Emerging Infectious Diseases |
Volume | 28 |
Issue number | 1 |
DOIs | |
Publication status | Published - Nov 2021 |
Keywords
- COVID-19
- Faroe Islands
- SARS
- SARS-CoV-2
- coronavirus
- coronavirus disease
- respiratory infections
- seroprevalence
- severe acute respiratory syndrome coronavirus 2
- viruses
- zoonoses